InfectiousICD-10: A56.2About 1.8 million reported cases annually in the U.S.

Chlamydia

Also known as: Chlamydial Infection, Chlamydia trachomatis Infection

Chlamydia is the most commonly reported sexually transmitted infection (STI) in the United States, caused by the bacterium Chlamydia trachomatis. It often has no symptoms, which means it can be unknowingly transmitted to sexual partners. If left untreated, chlamydia can cause serious reproductive health complications including pelvic inflammatory disease and infertility.

Last updated November 10, 2026

Understanding Chlamydia

Chlamydia is a bacterial infection of the genital tract, rectum, throat or eyes caused by Chlamydia trachomatis, and it is the most frequently reported infectious disease of any kind in the United States: about 1.65 million cases were reported to the CDC in 2023, and because most infections are silent and never tested, the true number of new infections each year is estimated at around 4 million. Nearly two thirds of reported cases are in people aged 15 to 24, and rates are highest in young women, partly because they are the group screened most. Roughly 70 to 95 percent of infected women and more than half of infected men have no symptoms at all, so the people who are diagnosed are usually found by routine screening or because a partner tested positive. The infection is passed through vaginal, anal or oral sex and from mother to baby at birth; it is not passed by kissing, sharing towels, toilets or pools. Having it says nothing about anyone's character; it is a common consequence of ordinary sex without a condom.

Chlamydia trachomatis is an obligate intracellular bacterium with a two-stage life cycle: a small, tough elementary body attaches to and enters the cells lining the cervix, urethra, rectum or throat, converts inside a membrane-bound inclusion into a larger reticulate body that divides for about 48 to 72 hours, and then reverts and bursts out to infect neighboring cells. The bacterium itself does little direct damage; the harm comes from the immune response it provokes, which with repeated or prolonged infection lays down scar tissue. In women, infection can ascend from the cervix into the uterus and fallopian tubes, causing pelvic inflammatory disease in roughly 10 to 15 percent of untreated cases; each episode of PID carries about a 10 percent risk of tubal infertility and a several-fold rise in ectopic pregnancy. In men it causes urethritis and, in 1 to 2 percent, epididymitis. Rectal infection causes proctitis, and any site of infection increases the chance of acquiring HIV. Some untreated infections clear on their own over a year, but you cannot know in advance which, and immunity is partial: reinfection within a year is common, at about 1 in 7 treated young women, mostly from an untreated partner.

Chlamydia is easy to diagnose and easy to treat, which is why screening matters more than symptoms. The test is a nucleic acid amplification test (NAAT) on urine or a self-collected vaginal, rectal or throat swab, with sensitivity above 95 percent; the US Preventive Services Task Force recommends it yearly for all sexually active women aged 24 and under and older women at increased risk, and the CDC recommends annual testing of exposed sites for men who have sex with men. The CDC's 2021 STI treatment guideline makes doxycycline 100 mg twice daily for 7 days the preferred treatment and azithromycin 1 g as a single dose the alternative, after trials showed azithromycin fails more often in rectal infection: in two 2021 randomized trials of men with rectal chlamydia, doxycycline cleared 100 percent of infections and azithromycin about three quarters. Azithromycin remains first choice in pregnancy, with a repeat test 4 weeks later to confirm clearance. Partners from the previous 60 days need treatment, and everyone treated should be retested at 3 months, because reinfection is so common. For men who have sex with men and transgender women with a recent STI, the CDC's 2024 guideline adds doxycycline 200 mg within 72 hours after sex (doxy-PEP), which cut chlamydia infections by 74 to 88 percent in a 501-person trial.

No herb, supplement or food treats chlamydia, and this is one condition where the honest answer should be blunt: garlic, goldenseal, echinacea, oregano oil, turmeric, colloidal silver and 'natural antibiotics' have never cleared a chlamydia infection in any human study, and the weeks spent trying them are weeks in which the bacteria can climb into the tubes. The only evidence-based supporting role for anything in the library is alongside the antibiotic. Probiotics taken during a doxycycline course reduce antibiotic-associated diarrhea by about half in pooled trials, with Saccharomyces boulardii and Lactobacillus rhamnosus GG the best studied. There is also an interesting but unproven line of research on the vaginal microbiome: women whose vaginal flora is dominated by Lactobacillus crispatus are less likely to acquire chlamydia in observational studies, and bacterial vaginosis roughly doubles the risk, but no trial has shown that taking a probiotic prevents infection, so the practical lesson is to get bacterial vaginosis treated rather than to buy capsules. Cranberry, d-mannose and 'urinary tract cleanse' products do nothing for chlamydia, which is not a bladder infection, and can mask the one symptom, burning on urination, that might otherwise prompt a test.

The most common mistake is resuming sex too soon. The rule is no sex, including oral sex, until 7 days after a single-dose azithromycin or until the last doxycycline tablet, and until every partner has finished treatment too; otherwise the infection simply passes back and forth between you. A close second is stopping doxycycline early because symptoms have gone or because of nausea; the 7-day course is the minimum, and the nausea is usually fixed by taking each dose with food and a full glass of water and staying upright for 30 minutes, which also prevents the capsule from lodging in the esophagus and ulcerating it. Do not take it within 2 hours of antacids, iron, calcium or dairy, which bind the drug, and expect to burn easily in the sun for the week. Finally, a negative urine test does not clear the throat or rectum; if those sites were exposed, ask for the swabs. Seek care the same day for pelvic pain with fever, pain during sex, or a swollen, painful testicle, which signal that the infection has spread.

At a Glance

Common symptoms
Often asymptomatic (up to 70% of women and 50% of men have no symptoms), Abnormal vaginal or penile discharge, Burning or pain during urination
Main treatments
Doxycycline (preferred first-line treatment), Azithromycin (single-dose alternative), Partner notification and treatment to prevent reinfection
Category
Infectious · About 1.8 million reported cases annually in the U.S.
See a doctor if
You experience abnormal genital discharge or pain during urination

Symptoms

Often asymptomatic (up to 70% of women and 50% of men have no symptoms)
Abnormal vaginal or penile discharge
Burning or pain during urination
Pain during sexual intercourse (women)
Testicular pain or swelling (men)
Lower abdominal or pelvic pain
Bleeding between periods or after sex (women)
Rectal pain, discharge, or bleeding (with rectal infection)

Causes

  • Infection with the bacterium Chlamydia trachomatis
  • Transmitted through vaginal, anal, or oral sexual contact
  • Can be passed from mother to infant during vaginal delivery

Risk Factors

  • Sexually active individuals under age 25
  • Multiple sexual partners
  • Not using condoms consistently
  • History of prior STIs
  • Having a partner with an STI

Diagnosis

  • Nucleic acid amplification test (NAAT) on urine or swab sample
  • Vaginal or cervical swab in women
  • Urethral swab or first-void urine in men
  • Rectal or pharyngeal swab if indicated

Treatment

  • Doxycycline (preferred first-line treatment)
  • Azithromycin (single-dose alternative)
  • Partner notification and treatment to prevent reinfection
  • Abstain from sexual activity for 7 days after treatment completion
  • Test of cure in 4 weeks for pregnant women
  • Retest 3 months after treatment to check for reinfection

Natural remedies for chlamydia: what the evidence says

Ranked by the strength of human evidence for chlamydia specifically. These sit alongside medical care, not in place of it.

  1. Saccharomyces Boulardii

    Moderate evidence

    This does nothing to chlamydia; its role is to make the 7-day doxycycline course easier to finish. A 2015 meta-analysis of 21 randomized trials (4,780 people) found S. boulardii taken alongside antibiotics roughly halved the risk of antibiotic-associated diarrhea (8.5 versus 17.2 percent), and a 2017 review of 17 outpatient trials (3,631 adults) found a similar 51 percent reduction for probiotics overall. Because it is a yeast, the antibiotic does not kill it, so timing of doses does not matter.

    Studied dose
    250 to 500 mg (5 to 10 billion CFU) of S. boulardii CNCM I-745 twice daily from the first antibiotic dose until a week after the last.
    Cautions
    Not for people with a central venous catheter, severe immune suppression or critical illness, in whom yeast bloodstream infections have occurred. Separate from antifungal drugs by 2 hours.
  2. Like S. boulardii, LGG is a supporting act for the antibiotic rather than a treatment for the infection. In the 2012 JAMA meta-analysis of 63 trials (11,811 people), probiotics reduced antibiotic-associated diarrhea by 42 percent, and LGG was one of the two best-supported strains; in a 2019 Cochrane review of 33 pediatric trials, high-dose LGG or S. boulardii cut diarrhea from 19 to 8 percent. It has not been tested specifically with doxycycline.

    Studied dose
    10 billion CFU once or twice daily during the antibiotic course and for a week after, taken at least 2 hours apart from each doxycycline dose so the antibiotic does not kill it.
    Cautions
    Avoid in people with a central venous catheter, severe immune deficiency or recent bowel surgery. Otherwise safe; mild bloating in the first days is common.
  3. Probiotics (Lactobacillus)

    Preliminary evidence

    Women whose vaginal microbiome is dominated by Lactobacillus crispatus have lower rates of chlamydia acquisition in cohort studies, and bacterial vaginosis, where lactobacilli are depleted, roughly doubles the risk of catching it. That is the rationale for vaginal probiotics, but it has not been shown to work: no randomized trial has tested whether an oral or vaginal probiotic prevents chlamydia, and the strains sold in capsules are mostly not L. crispatus. It is a hypothesis, not a treatment, and it has no effect on an existing infection.

    Studied dose
    No dose has been shown to prevent or treat chlamydia; products studied for restoring vaginal flora after bacterial vaginosis use 1 to 10 billion CFU daily of L. crispatus or L. rhamnosus GR-1 plus L. reuteri RC-14.
    Cautions
    Safe in healthy adults. Do not use it in place of testing, treatment or condoms, and get bacterial vaginosis diagnosed and treated rather than self-managing it with probiotics.

What matters day to day

  • Use a condom for vaginal and anal sex and a condom or dental dam for oral sex with new or non-exclusive partners: chlamydia passes through the fluids and mucous membranes that a barrier covers, and consistent use is the single most effective prevention short of mutual monogamy with a tested partner.
  • Get tested once a year until you turn 25, and after every new partner at any age, asking for throat and rectal swabs if those sites are exposed: a urine test misses rectal and throat infections, which are often symptomless and can seed genital reinfection.
  • Tell every partner from the past 60 days, or your most recent partner if it has been longer: untreated partners are the source of most reinfections, and if talking directly is impossible, free anonymous notification services and expedited partner therapy exist precisely for this.
  • Put the 3-month retest in your calendar the day you are treated: about 1 in 7 young women and a similar share of men test positive again within a year, almost always from reinfection, and the second infection carries a higher risk of pelvic inflammatory disease than the first.
  • Take doxycycline with a meal and a full glass of water, stay upright for 30 minutes, and keep it 2 hours away from antacids, iron, calcium supplements and dairy; wear sunscreen for the week, because doxycycline makes sunburn likely within minutes of exposure.
  • Do not douche: douching strips the protective lactobacilli from the vagina and pushes bacteria upward, and in a case-control study women who douched had about 70 percent higher odds of pelvic inflammatory disease.

Prevention

  • Use condoms consistently and correctly during sexual activity
  • Get screened annually if sexually active and under 25
  • Limit number of sexual partners
  • Ensure sexual partners are tested and treated

When to See a Doctor

  • You experience abnormal genital discharge or pain during urination
  • A sexual partner has been diagnosed with an STI
  • You are sexually active and have not been screened recently
  • You are pregnant and have not been tested for STIs

Frequently Asked Questions

References

  1. Workowski KA, Bachmann LH, Chan PA, et al.. Sexually transmitted infections treatment guidelines, 2021. MMWR Recommendations and Reports (2021)
  2. US Preventive Services Task Force. Screening for chlamydia and gonorrhea: US Preventive Services Task Force recommendation statement. JAMA (2021)
  3. Lau A, Kong FYS, Fairley CK, et al.. Azithromycin or doxycycline for asymptomatic rectal Chlamydia trachomatis. New England Journal of Medicine (2021)
  4. Dombrowski JC, Wierzbicki MR, Newman LM, et al.. Doxycycline versus azithromycin for the treatment of rectal chlamydia in men who have sex with men: a randomized controlled trial. Clinical Infectious Diseases (2021)
  5. Luetkemeyer AF, Donnell D, Dombrowski JC, et al.. Postexposure doxycycline to prevent bacterially transmitted infections. New England Journal of Medicine (2023)
  6. Bachmann LH, Barbee LA, Chan PA, et al.. CDC clinical guidelines on the use of doxycycline postexposure prophylaxis for bacterial sexually transmitted infection prevention, United States, 2024. MMWR Recommendations and Reports (2024)
  7. Hosenfeld CB, Workowski KA, Berman S, et al.. Repeat infection with chlamydia and gonorrhea among females: a systematic review of the literature. Sexually Transmitted Diseases (2009)
  8. Haggerty CL, Gottlieb SL, Taylor BD, et al.. Risk of sequelae after Chlamydia trachomatis genital infection in women. Journal of Infectious Diseases (2010)
  9. Blaabjerg S, Artzi DM, Aabenhus R. Probiotics for the prevention of antibiotic-associated diarrhea in outpatients: a systematic review and meta-analysis. Antibiotics (Basel) (2017)
  10. MedlinePlus, National Library of Medicine. Chlamydia Infections (2024)View source

Related Conditions

Have questions about Chlamydia?

Ask Mother Nature AI for personalized, evidence-based guidance.

Medical Disclaimer: This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider.

Content reviewed against peer-reviewed medical literature and clinical guidelines. Read our editorial standards.